Ethics Consult: Deaf Couple Only Wants Deaf Baby You make the call: should doctor implant embryo selected for deafness? Oct 04, 2019
New Drug Alternative for Cushing's Syndrome? Levoketoconazole proved effective, but not clearly superior Oct 04, 2019
How Common Are Inaccurate Coronary Artery Calcium Scans? The Skeptical Cardiologist finds reason to suspect the MAC Oct 04, 2019
Entresto Approved for Children Symptomatic HF population as young as 1 year given the green light Oct 03, 2019
Does Zantac Break Down Into a Carcinogen? Rather than contamination, "the fundamental problem is that it's an unstable molecule" Oct 03, 2019
First-Line Combo Boosts PFS in Untreated Bladder Cancer 'Clinically meaningful' trend in OS with atezolizumab-chemotherapy Oct 03, 2019
In Memory of Gerald Chodak, MD Pioneer of active surveillance for men with low-risk prostate cancer died last week Oct 03, 2019
Tennis Star Swings Back at Rheumatoid Arthritis Caroline Wozniacki hopes her nearly debilitating condition inspires others Oct 03, 2019
New Standard in Third-Line Metastatic CRPC Cabazitaxel tops more anti-androgen in patients with "short-ish" response to abiraterone or enzalutamide Oct 01, 2019
Novel CDK 4/6 Inhibitor Fails in Triple Negative Breast Cancer Misses primary endpoints but has unexpected key benefit Oct 01, 2019
Pamrevlumab Appears Safe, Effective for IPF Findings "striking" but should be "treated with caution," expert warns Oct 01, 2019
NK3R Antagonist Promising for Vasomotor Symptoms in Menopause Appeared safe and effective, despite large placebo effect Sep 30, 2019
Benralizumab: A Second Chance in Patients With COPD? Findings are hypothesis-generating but "invaluable," one researcher says Sep 30, 2019
Why Did Rare Cancer Shrink on Its Own? Case illustrates the mystery of spontaneous regression Sep 30, 2019
Neoadjuvant Anti-PD-1 Boosts pCR in TNBC Favorable trend toward improved event-free survival in preliminary analysis Sep 30, 2019
Trametinib Tx Shows Promise in Tough-to-Treat LGSOC Targeted drug provokes good response in chemoresistant, low-grade serous ovarian or peritoneal cancer Sep 30, 2019
OCT Vs FFR: Which Is the Better Guide for Revascularization? Optical coherence tomography goes up against physiological guidance in angiographically intermediate coronary lesions Sep 30, 2019
TAVR at 5 Years: Paravalvular Regurgitation is Key "No matter what you're using, you have to decrease PVR" Sep 29, 2019
Data Support 'Best Drug First' in EGFR-Mutant NSCLC Six-month survival gain with osimertinib, adding to PFS, safety advantages Sep 29, 2019
CDK 4/6 Inhibitors Boost OS in Advanced Breast Cancer Abemaciclib, ribociclib should become first-line treatment in HR-positive/HER2-negative disease, expert says Sep 29, 2019
Cannabis for Symptomatic Menopause: Cultivating the Evidence Oyedeji Ayonrinde, FRCPsych, MBA, weeds out the known and unknown Sep 29, 2019
PARP Inhibitors: The Key to a Tx Paradigm Shift in Ovarian Ca? PRIMA and VELIA trial findings advance niraparib and veliparib to the therapeutic front lines Sep 29, 2019
MitraClip for Functional MR: 'It's Never Too Late' Benefit grows versus meds over time and not hurt by delay in COAPT trial Sep 29, 2019
Abemaciclib Offers Hope in HR+/HER2+Breast Cancer Phase II monarcHER trial shows better PFS with abemaciclib-trastuzumab-fulvestrant Sep 29, 2019
First-Line Combo Boosts PFS in Advanced Ovarian Ca Olaparib-bevacizumab maintenance boosts PARP inhibitor benefits beyond BRCA-mutated subgroup Sep 28, 2019
Heavy Drinking Among Middle-Aged Women: A Sobering Issue What can doctors do to better screen, treat this population? Sep 28, 2019
Paclitaxel Device Scare Highlights PAD Research Flaws Latest data from the Lutonix research program reassuring, but far from conclusive Sep 28, 2019
Advanced HCC Trial Misses OS Endpoint But CheckMate 459 researchers tout "encouraging efficacy and favorable safety profile" Sep 28, 2019
EXCEL: Left Main Stenting Holding Up to CABG at 5 Years The trial held a mortality surprise, though Sep 28, 2019
Notable OS Gains with Dual Immunotherapy in Advanced NSCLC Secondary analysis of CheckMate 227 brings more good news for nivolumab-ipilimumab combo Sep 28, 2019
Mitral Valve Procedure Learning Curve Raises Access Question And guess which procedures are next for public outcome reporting... Sep 27, 2019
Novel TAVR Valves: Mixed Results in First Head-to-Head Trials With one a clear loser, another noninferior to existing devices, will operators want to climb the learning curve? Sep 27, 2019
Post-AVR Leaflet Thrombosis Often Vanishes Sans Treatment Even so, PARTNER 3 substudy found more clinical events with leaflet thickening Sep 27, 2019
Durable-, Bioresorbable-Polymer DES Vie for Short DAPT Studies explore left main disease, high bleeding risk populations Sep 27, 2019
Bariatric Surgery May Compromise Mental Health Patients with psychiatric history saw higher rate of repeat presentations Sep 26, 2019
CKD Patients With Osteoporosis Benefit From New Drug New FRAME analysis backs use of romosozumab in this population Sep 26, 2019
Patient Data Makes a Slight Dent in Paclitaxel Device Mortality Risk New meta-analysis still shows risk persists Sep 26, 2019
Dropping Aspirin Early After Stenting Helps High-Risk Patients TWILIGHT trial has good news for safety Sep 26, 2019
